{
    "clinical_study": {
        "@rank": "92228", 
        "acronym": "Probono1", 
        "arm_group": [
            {
                "arm_group_label": "Controls, females", 
                "description": "Controls who are presumed HIV uninfected, females, aged 18 or above"
            }, 
            {
                "arm_group_label": "Controls, males", 
                "description": "Controls presumed HIV uninfected, males, aged 18 or above"
            }, 
            {
                "arm_group_label": "HIV infected patients, males", 
                "description": "HIV patients, males, aged 18 or above"
            }, 
            {
                "arm_group_label": "HIV patients,", 
                "description": "HIV patients, females, aged 18 or above"
            }
        ], 
        "biospec_descr": {
            "textblock": "Plasma and urine"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the bone mineral density in male and female\n      patients with HIV infection according to age groups.\n\n      This will enable a practical approach to screening for osteoporosis and the management and\n      prevention of fragility fractures in people with HIV.\n\n      In addition, all risk factors commonly associated with fragility fractures and osteoporosis\n      are collected, as is HIV drug history.\n\n      Hence, as secondary outcomes, the associations with reduced bone mineral density can be\n      ascertained."
        }, 
        "brief_title": "Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Osteoporosis", 
            "Fractures", 
            "HIV Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Fractures, Bone", 
                "Osteoporosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or above Not pregnant Able to comply with study observations and procedures\n             Able to give fully informed consent\n\n        Exclusion Criteria:\n\n          -  Pregnant Less than 18 years of age Unable to comply with study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A randomly recruited numbers of HIV uninfected controls and HIV patients aged 18 years or\n        above, equally matched for age, and gender."
            }
        }, 
        "enrollment": {
            "#text": "440", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669954", 
            "org_study_id": "RJ1 09/0329", 
            "secondary_id": "08/H0805/56"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HIV", 
            "Bone mineral density", 
            "Osteoporosis", 
            "Vitamin D", 
            "Fractures"
        ], 
        "lastchanged_date": "August 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "zip": "SE30AA"
                }, 
                "name": "St Thomas, Hospital"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "4", 
        "official_title": "Prospective Study to Determine the Optimum Age for Routine DEXA Screening for Osteopenia/Osteoporosis in People With HIV Infection", 
        "overall_official": {
            "affiliation": "King's College London", 
            "last_name": "Barry S Peters, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Bone mineral density as determined by DXA scanning", 
            "measure": "Bone mineral density at Hip", 
            "safety_issue": "No", 
            "time_frame": "The outcome is measured within 6 months (0-6 months) after entry to the study."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669954"
        }, 
        "responsible_party": {
            "investigator_affiliation": "King's College London", 
            "investigator_full_name": "Barry Stephen Peters", 
            "investigator_title": "Reader and Consultant HIV Medicine, Head of Research Unit, Principle Investigator, Clinical Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "As determined by DXA scan", 
                "measure": "Bone mineral density at spine (L4)", 
                "safety_issue": "No", 
                "time_frame": "The outcome is measured within 6 months (0-6 months) after entry to the study."
            }, 
            {
                "description": "Self-reported fractures of any type", 
                "measure": "Any lifetime fractures reported by subjects", 
                "safety_issue": "No", 
                "time_frame": "At any stage during persons life up to and including the last visit for the volunteer to the study."
            }, 
            {
                "description": "Plasma vitamin D", 
                "measure": "Vitamin D levels", 
                "safety_issue": "No", 
                "time_frame": "The outcome is measured within 6 months (0-6 months) after entry to the study."
            }
        ], 
        "source": "King's College London", 
        "sponsors": {
            "collaborator": {
                "agency": "St Thomas' Hospital, London", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "King's College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2009", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}